Efficient syntheses of some 4-thiazolidinones are described. A series of 2-(substituted phenyl)-3-[4-(2,4-dichloro-5-fluorophenyl)-6-(2-thienyl)pyrimidine-2-yl-ureido]-5H/methyl/carboxymethyl-4-thiazolidinones 5a-e,6a-e,7a-e were prepared. The structures of the synthesised compounds were assigned on the basis of elemental analysis, IR and 1 H NMR spectral data. All the products were screened against different strains of bacteria and fungi.
Introduction
The presence of a pyrimidine nucleus in compounds, often leads to exceptionally interesting biological and pharmacological activities. 4-Thiazolidinones have been reported to show a broad spectrum of biological activities. [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] The pharmacological properties of 4-thiazolidinones encouraged our interest in synthesizing several new compounds featuring various heterocyclic rings, attached to 4-thiazolidinone moieties. As a part of our aim to search for biologically active heterocycles containing sulfur and nitrogen, we have now synthesised a series of 2-(substituted phenyl)-3-[4-(2,4-dichloro-5-fluorophenyl)-6-(2-thienyl) pyrimidine-2-yl-ureido]-5H / methyl / carboxymethyl-4-thiazolidinones 5a-e, 6a-e, 7a-e . 2,4-Dichloro-5-fluoroacetophenone on reaction with thiophene-2-carbaldehyde in a ClaisenSchmidt condensation 11-13 gave 1-(2,4-dichloro-5-fluorophenyl)-3-(2-thienyl)-2-propen-1-one 1 (Scheme 1), which on reaction with guanidine nitrate and 40% KOH yielded 2-amino-4-(2,4-dichloro-5-fluorophenyl)-6-(2-thienyl)pyrimidine 2 (Scheme 2) in 70% yield. 
Scheme 2
Compound 2 on further reaction with methyl chloroformate (MCF) followed by reaction with hydrazine hydrate gave 4-[4-(2,4-dichloro-5-fluorophenyl)-6-(2-thienyl)pyrimidin-2-yl] semicarbazide 3 in 68% yield. Compound 3 on condensation with various substituted aromatic aldehydes afforded 1-(substituted benzylidene)-4-[4-(2,4-dichloro-5-fluorophenyl)-6-(2-thienyl)pyrimidin-2-yl] semicarbazides 4a-e (Scheme 3). These imines on cyclocondensation with mercaptoacetic acid (X = H), 2-mercaptopropanoic acid (X = CH 3 ) or mercaptosuccinic acid (X = CH 2 COOH) respectively led to the formation of 2-(aryl)-3-[4-(2,4-dichloro-5-fluorophenyl)-6-(2-thienyl)pyrimidin-2-yl-ureido]-5H / methyl / carboxymethyl-4-thiazolidinones 5a-e, 6a-e,7a-e (Scheme 3) .
Results and Discussion
The results given in Table 1 5a-e, 6a-e, 7a-e Scheme 3. R = aryl; X = H (5a-e), CH 3 (6a-e), CH 2 COOH (7a-e).
In the 1 H NMR spectrum of 1, the signal at δ 7.1 corresponded to the COCH=CH unit. A signal at δ 6.8 for the CH (pyrimidine ring) verified the structure 2. In the same way, the disappearance of the signal at δ 5.1 due to NH 2 and the appearance of a signal at δ 4.4 due to N=CH provided further evidence for the conversion of compound 3 into compound 4. Finally the 
Antibacterial activity
All the synthesised compounds were screened for their in vitro antibacterial activity against Escherichia coli (ATCC 8739), Pseudomonas aureginosa (ATCC 1539) and Staphylococcus aureus (ATCC 6538), Bacillus substilis (ATCC 6633) bacteria using the cup-plate agar diffusion method.
14 Streptomycin was used as reference drug. The degree of inhibition varied with the test compound as well as with the bacterium. Against Bacillus substilis (ATCC 6633), compounds 5a, 5d, 6d, 6e, 7a, 7c exhibited good antibacterial activity, whereas compounds 5b, 5c, 6e, 6c, 7b, 7e showed low activity. On the other hand Pseudomonas aureginosa (ATCC 1539) showed poor responses to five of the prepared products. Compounds 5d, 6d, 7c and compounds 5a, 6d, 7b exhibited good antibacterial activity towards Escherichia coli (ATCC 8739) and Staphylococcus aureus (ATCC 6538) respectively.
On the basis of the antibacterial activity data it could be concluded that some of the compounds possess considerable antibacterial activity due to the presence of methoxy, fluoro and chloro groups. However the activity of the tested compounds is less than that of streptomycin.
Antifungal activity
The compounds were tested for their antifungal activity using Candia crusei (ATCC 14243) and Candida albicans (ATCC 64550) . For all compounds, the minimum inhibitory concentration (MIC) was taken as the lowest concentration at which there was 100% inhibition of growth compared with the growth for a drug-free control. 15 Griseofulvin was used as reference drug for comparison. The data of antifungal activity (Table 1) showed that generally, the compounds 5a, 5d, 6c, 6d, 7b, 7c were more effective against Candia crusei (ATCC 14243), while compounds 5b, 6a, 6b, 7d, 7e exhibited low antifungal activity. Moreover, compounds 5a, 5b, 6e, 7e demonstrated good activity against Candida albicans (ATCC 64550). On the basis of the antifungal activity data it could be concluded that some of the compounds possess good activity. however, none of compounds was superior to standard used against any of the fungi.
Experimental Section
General Procedures. Melting points were determined in an open capillary tube and are uncorrected. Infrared (IR) Spectra were measured on a FTIR-8400 Shimadzu spectrometer using KBr pellets. The proton nuclear magnetic resonance ( 1 H NMR) spectra were recorded on a Brüker Avance dpx-200 (at 200 MHz) spectrometer with CDCl 3 as a solvent with tetramethylsilane (TMS) as an internal reference. Chemical shifts are expressed in δ ppm. Elemental analysis of C and H was performed by Central Drug Research Institute, Lucknow and nitrogen was estimated by Kjeldhal's method, 16 results are within ± 0.4% of the theoretical value.
Thin layer chromatography was carried out on silica gel (Kieselgel G; Merck) to monitor the reactions and to check the purity of the compounds. All reagents were of the highest purity available commercially. 2-(4-Fluorophenyl)-3-[4-(2,4-dichloro-5-fluorophenyl)-6-(2-thienyl) 
1-(2,4-Dichloro-5-fluorophenyl-3-(2-thienyl)-2-propen-

